MONIKA HOLDER: Open Payments
NPI 1245524529 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 53 payments from 16 companies in 2025. Trend: 2023 $2,548 · 2024 $2,323 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 9 | $203 |
| Janssen Biotech, Inc. | 7 | $169 |
| UCB, Inc. | 3 | $115 |
| ABBVIE INC. | 5 | $97 |
| GENZYME CORPORATION | 3 | $89 |
| Incyte Corporation | 3 | $79 |
| Galderma Laboratories, L.P. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Amgen Inc. | 3 | $61 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $61 |
Products named: SOFDRA, TREMFYA, DUPIXENT, Bimzelx, OPZELURA, OTEZLA, NEMLUVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
